bencyclane has been researched along with Arteriosclerosis Obliterans in 1 studies
Bencyclane: A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.
Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jonderko, G | 1 |
| Szramek-Urbaniak, A | 1 |
| Bednarczyk-Kałuzna, M | 1 |
1 other study available for bencyclane and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
[Usefulness of vasodilator agents Cavinton and Halidor in circulatory insufficiency of the lower limbs].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Bencyclane; Cycloheptanes; Diabetic Angiopathies; Female; | 1982 |